Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

16.89EUR
23 May 2018
Change (% chg)

€0.02 (+0.12%)
Prev Close
€16.87
Open
€16.89
Day's High
€16.89
Day's Low
€16.57
Volume
9,019
Avg. Vol
28,348
52-wk High
€29.97
52-wk Low
€15.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 1.58 -1.516
Jun '17 1.79 -1.420
FY 2016 Dec '16 1.74 -1.433
Jun '16 2.40 -1.310
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 1.50 3.00 0.00 14.00
Year Ending Dec-19 4 11.65 19.00 7.00 9.50
Earnings (per share)
Year Ending Dec-18 2 -2.03 -2.00 -2.06 -1.82
Year Ending Dec-19 5 -2.50 -1.91 -3.00 -2.73
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta 0.86 0.90 0.88
Price to Sales (TTM) 80.61 110.95 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) -- 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions -- 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -8.67 78.86 5.69
Sales - 5 Yr. Growth Rate 35.25 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate 81.34 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) -- 5.29 2.98
LT Debt to Equity (MRQ) -- 22.98 12.17
Total Debt to Equity (MRQ) -- 24.63 16.44
Interest Coverage (TTM) -- -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -575.09 10.96
Operating Margin (TTM) -736.87 -718.94 4.73
Operating Margin - 5 Yr. Avg. -331.17 -596.41 6.40
Pre-Tax Margin (TTM) -727.19 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -337.58 -599.76 6.82
Net Profit Margin (TTM) -727.87 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -337.31 -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 22,637,573 847,034,055
Net Income/Employee (TTM) -301,682 2,973,815 99,640,144
Receivable Turnover (TTM) -- 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) -- 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.09 10.95
Return on Assets - 5 Yr. Avg. -38.25 -0.58 12.32
Return on Investment (TTM) -- 1.57 14.38
Return on Investment - 5 Yr. Avg. -46.07 2.21 16.11
Return on Equity (TTM) -- 2.43 16.07
Return on Equity - 5 Yr. Avg. -51.29 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 37 53
13 Week -7.07 -10.79 76 65
26 Week -12.20 -15.88 77 77
52 Week 35.52 13.27 99 50
YTD 76.06 59.71 99 58
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 47.70%
# of Holders: 25
Total Shares Held: 8,556,470
3 Mo. Net Change: -23,474
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 2
# Reduced Positions: 3
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.